Results 131 to 140 of about 33,525 (245)

Spotlight July–September 2026: What's New in JEADV—Editor‐in‐Chief's Selection

JEADV Clinical Practice, Volume 5, Issue 3, Page 763-768, September 2026.
Carle Paul
wiley   +1 more source

When to consider an inborn error of immunity: clues for physicians

Internal Medicine Journal, Volume 56, Issue 9, Page 1488-1499, September 2026.
Abstract The term inborn errors of immunity (IEIs) refers to the rapidly expanding group of genetic disorders causing dysregulation of the immune system. With improved genetic testing in recent years, the number of defined IEIs and their range of phenotypic presentations has grown vastly, with more than 550 IEIs now described.
Meera Thangarajah, Lucinda J. Berglund
wiley   +1 more source

Omega Fatty Acids in Hair Loss Disorders: A Scoping Review of Preclinical and Clinical Evidence

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Omega fatty acids, including polyunsaturated omega‐3 and omega‐6 fatty acids (PUFAs) and monounsaturated omega‐9 fatty acids, regulate inflammation, cellular signaling, and tissue homeostasis, and may influence hair follicle biology and hair growth.
Nana‐Hawwa Abdul‐Rahman, Jacqueline D. Wang, Miriam Motlak, Gerardo Guiltarte, Reethi S. Padmanabhan, Ellen T. Lee, Sonal Choudhary   +6 more
wiley   +1 more source

Efficacy of Baricitinib in Moderate Alopecia Areata, Severe Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Real-world Comparative Study.

This dataset supports the findings in the manuscript "Efficacy of Baricitinib in Moderate Alopecia Areata, Severe Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Real-world Comparative Study." The dataset includes:Demographic and baseline ...
Jiang, Guan
core   +1 more source

PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 759-761, September 2026.
Annie Jin, Katherine T. Steele, Emily Y. Chu   +2 more
wiley   +1 more source

Quality of life in alopecia areata

, 2009
Alopecia areata is a recurrent, nonscarring type of hair loss; it is an autoimmune disease mediated by T lymphocytes, often resistant to multiple therapies. The aim of the study was to evaluate the quality of life in people with alopecia areata.
Antonella Tosti, FABBROCINI, GABRIELLA, Débora Cadore de Farias, Colombina Vincenzi   +3 more
core  

JAK inhibitors and menstrual cycle alterations: insights from a case series of 16 female patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page e1338-e1340, September 2026.
Luciano Ibba, Luigi Gargiulo, Matteo Bianco, Sara Di Giulio, Ruggero Cascio Ingurgio, Angela Alfano, Carlo A. Vignoli, Mario Valenti, Paola Facheris, Chiara Perugini, Alessandra Narcisi, Antonio Costanzo   +11 more
wiley   +1 more source

Complementing baricitinib response in late-responding alopecia areata through alternating weekly double combination of topical corticosteroids: A split-scalp comparison

JAAD Case Reports
Calogero Pagliarello, MD, PhD, Carlo Renè Girardelli, MD   +1 more
doaj   +1 more source

JAK‐Inhibitoren und Veränderungen des Menstruationszyklus: Erkenntnisse aus einer Fallserie mit 16 Patientinnen

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page 1338-1340, September 2026.
Luciano Ibba, Luigi Gargiulo, Matteo Bianco, Sara Di Giulio, Ruggero Cascio Ingurgio, Angela Alfano, Carlo A. Vignoli, Mario Valenti, Paola Facheris, Chiara Perugini, Alessandra Narcisi, Antonio Costanzo   +11 more
wiley   +1 more source

Assessing Alopecia Areata Misinformation: Social Media Analysis. [PDF]

JMIR Dermatol
Francis SN, Agarwal AA, Fanous AH, Siegel DH, Daneshjou R.   +4 more
europepmc   +1 more source